Feasibility of Serum Galectin-1 as a Diagnostic Biomarker for Metabolic Dysfunction-Associated Steatotic Liver Disease: A Study on a Segment of the Chinese Population Using Convenience Sampling

Feasibility of Serum Galectin-1 as a Diagnostic Biomarker for Metabolic Dysfunction-Associated Steatotic Liver Disease: A Study on a Segment of the Chinese Population Using Convenience Sampling

<b>Background/Objectives</b>: Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) is commonly considered as a hepatic manifestation of metabolic syndrome, posing considerable public health and economic challenges due to its high prevalence. This study investigates the diagno...

Full description

Saved in:
Bibliographic Details
Main Authors: Ting Zeng, Fang Li, Min Yang, Yao Wu, Wei Cui, Huaming Mou, Xiaohe Luo
Format: Article
Language:English
Published: MDPI AG 2025-02-01
Series:Biomedicines
Subjects:
metabolic dysfunction-associated steatotic liver disease
serum galectin-1 levels
diagnostic marker
fatty liver index
hepatic steatosis index
Online Access:https://www.mdpi.com/2227-9059/13/2/425
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items